Relationships with Industry and Other Entities
| Workgroup member | Conflict of interest |
|---|---|
| Javier Arbizu, MD, PhD | Clinical research for Araclon Biotech; institution received research support from Life Molecular Imaging; served as a consultant for Eli Lilly |
| Tammie L.S. Benzinger, MD, PhD | Consultant for Lilly, Biogen, Eisai, and Johnson & Johnson; investigator initiated research funded by Siemens |
| Kevin Donohoe, MD | The author declares that there is no conflict of interest |
| Oskar Hansson, MD, PhD | Institution received research support from ADx, AVID Radiopharmaceuticals, Biogen, Eli Lilly, Eisai, Fujirebio, GE Healthcare, Pfizer, and Roche; in the past 2 y has received consultancy/speaker fees from AC Immune, Amylyx, Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi, and Siemens |
| Peter Herscovitch, MD | Associate Editor for Sage Publishing |
| Keith Johnson, MD | Clinical trial for Cerveau Technologies and consultant for Novartis, Genentech, Jansson, Takeda, Merck, and Prothena |
| David Knopman, MD | The author declares that there is no conflict of interest |
| Phillip H. Kuo, MD, PhD | Consultant or speaker for Blue Earth Diagnostics, Chimerix, Eli Lilly, Fusion Pharma, General Electric Health Care, Invicro, Novartis, Radionetics, and Telix Pharmaceuticals; recipient of research grants from Blue Earth Diagnostics and General Electric Health Care |
| Jennifer Hagerty Lingler, PhD | Consultant to Biogen and Genentech and has received research support from Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly |
| Satoshi Minoshima, MD, PhD | Consultant and received educational donation from Hamamatsu Photonics, research grant from Hitachi, and education donation from Nihon Medi-Physics Co., Ltd. |
| Melissa E. Murray, PhD | Consulted for AVID Radiopharmaceutical and receives research support from Eli Lilly |
| Julie C. Price, PhD | The author declares that there is no conflict of interest. |
| Gil Rabinovici, MD | Institution received research support from Avid Radiopharmaceuticals, GE Healthcare, Life Molecular Imaging, and Genentech; served as a consultant for Eli Lilly, Johnson & Johnson, and Merck |
| Stephen Salloway, MD, MS | Institution received research support for clinical trials from Biogen, Janssen, Eisai, Lilly, Genentech, and Roche; served as a consultant for Merck, Novo Nordisk, and Acumen |
| Christopher J. Weber, PhD | Full-time employee of the Alzheimer’s Association. No financial conflicts to disclose. |
| Maria C. Carrillo, PhD | Full-time employee of the Alzheimer’s Association and has a daughter in the neuroscience program at USC; no financial conflicts to disclose |